Results 71 to 80 of about 15,332 (223)
Candida auris: an Emerging Fungal Pathogen [PDF]
Journal of Clinical Microbiology, 2018 ABSTRACT Candida auris has emerged globally as a multidrug-resistant health care-associated fungal pathogen. Recent reports highlight ongoing challenges due to organism misidentification, high rates of antifungal drug resistance, and significant patient mortality.
Emily S, Spivak, Kimberly E, Hanson
openaire +2 more sources
Mycoses, Volume 69, Issue 2, February 2026.ABSTRACT Background Candida (Candidozyma) auris is an emerging yeast that poses a significant global health threat due to its multidrug resistance and ability to cause healthcare‐associated outbreaks. Genomic surveillance is essential for monitoring spread, transmission and antifungal resistance.
Luiz Marcelo Ribeiro Tomé +19 more
wiley +1 more source
mSystems, 2021 Candida auris is a recently described multidrug-resistant pathogenic fungus that is increasingly responsible for health care-associated outbreaks across the world. Bloodstream infections of this fungus cause death in up to 70% of cases.
Daniel Zamith-Miranda +10 more
doaj +1 more source
Sentinel Case of Candida auris in the Western United States Following Prolonged Occult Colonization in a Returned Traveler from India. [PDF]
, 2019 Candida auris is an emerging multidrug-resistant yeast with high mortality. We report the sentinel C. auris case on the United States West Coast in a patient who relocated from India.
Crawford, Emily D +12 more
core +1 more source
Mitochondria as a Potential Antifungal Target for Isocyanide Compounds [PDF]
, 2020 The discovery of antibiotics and antifungals greatly impacted medicine and human health, allowing the effective treatment of infections that were previously deadly. However, due to routine and sometimes excessive usage of these compounds, the development
Berkowitz, David +5 more
core +1 more source
Can Intravenous Antifungal therapy be safely used in the Outpatient Parenteral Antimicrobial Therapy (OPAT) setting? [PDF]
, 2019 Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients with a variety of infections who require a period of intravenous therapy, are clinically stable, and do not require continuous monitoring.
Kenny, Claire +2 more
core +2 more sources
Candida auris: Epidemiology, biology, antifungal resistance, and virulence.
PLoS Pathogens, 2020 First described in 2009 in Japan, the emerging multidrug-resistant fungal pathogen Candida auris is becoming a worldwide public health threat that has been attracting considerable attention due to its rapid and widespread emergence over the past decade ...
Han Du +5 more
doaj +1 more source
First report of sporadic cases of Candida auris in Colombia
International Journal of Infectious Diseases, 2018 Background: Candida auris is a recently reported Candida species that is phenotypically similar to Candida haemulonii and related to hospital outbreaks.
Claudia M. Parra-Giraldo +11 more
doaj +1 more source
Boletín Micológico, 2019 C. auris es una levadura que debe preocupar a todos los clínicos y laboratorios de los distintos recintos hospitalarios del país, debido a las dificultades que presenta para poder identificarla y por la resistencia a las principales familias de antifúngicos de uso habitual.
openaire +1 more source
Plasma Processes and Polymers, Volume 23, Issue 1, January 2026.The research focused on the distribution of RONS on the agar surface, their concentration, and the bacterial inhibition halo. The findings show that changing the gas mixture alters RONS levels, thereby altering the dominant RONS and affecting the levels of others during plasma exposure. Created in BioRender. Silva, D. (2025).
Diego Morais da Silva +5 more
wiley +1 more source